ZLD — Zelira Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$4.16m
- AU$6.47m
- AU$0.00m
Annual cashflow statement for Zelira Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -1.63 | -1.09 | -0.757 | -0.941 | -0.946 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.62 | -9.43 | -7.25 | -4.39 | -4.91 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.38 | -0.208 | 2.83 | 0.92 | 1.15 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.38 | -0.208 | 2.83 | 0.92 | 1.15 |
| Financing Cash Flow Items | -0.088 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.5 | 7.1 | 1.77 | 3.92 | 3.19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.27 | -2.22 | -2.6 | 0.44 | -0.581 |